{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibgkxgyfozxfyk34ucm4fdkh6cekn6pivd2bft7by2hudbm7lswdm",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mnq7oiymnpz2"
  },
  "path": "/2026/06/06/ractigen-therapeutics-announces-ada-2026-late-breaking-presentation-highlighting-sarna-as-a-new-frontier-in-obesity-control/",
  "publishedAt": "2026-06-06T00:30:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass and preventing post-treatment weight rebound. NEW ORLEANS, June 6, 2026 /PRNewswire/ — Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that a late-breaking […]",
  "title": "Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control"
}